In-hospital outcomes following sleeve gastrectomy and Roux-en-Y gastric bypass: a real-world multicenter study in Germany
Langenbeck's Archives of Surgery · 30.04.2026 · 411 (1)
DOI: 10.1007/s00423-026-04064-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Langenbeck's Archives of Surgery, online erschienen am 30.04.2026. Verfasst von Sarah Krieg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical School and University Medical Center OWL, Mara Hospital, University Clinic for People with Neurodevelopmental Disorders, Bielefeld University…. Hauptthemen laut MEDLINE: Gastric Bypass, Gastrectomy, Obesity, Morbid, Laparoscopy. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ruhr-Universität Bochum.
Abstract (Originalsprache)
Purpose
Metabolic bariatric surgery (MBS) is an effective treatment for severe obesity. While randomized trials have shown comparable medium-term outcomes for laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (LRYGB), real-world data on perioperative safety remain limited. This study compares in-hospital mortality, complications, and length of stay between LSG and LRYGB in a large German cohort.
Methods
We performed a cross-sectional analysis of anonymized hospital data from 49 German institutions (January 2019–January 2024), including 3,389 MBS procedures (LSG: n = 2,664; LRYGB: n = 725). Outcomes included in-hospital mortality, defined perioperative complications (e.g., hemorrhage, infection, anastomotic leak), and length of hospital stay. Logistic regression adjusted for age, sex, BMI categories, and comorbidities was used to assess associations.
Results
Most individuals (69.1%) had a BMI ≥ 40 kg/m². LSG was more common in individuals with BMI ≥ 50 kg/m², whereas LRYGB was preferred in individuals with lower BMI and higher metabolic burden. In-hospital mortality was low: two deaths occurred after LRYGB (0.3%), none after LSG. Overall complication rates were similar (LSG: 3.9%; LRYGB: 4.1%). We did not observe statistically significant differences in complication risk; however, confidence intervals were wide, reflecting limited statistical power. Median length of hospital stay was three days for both groups; prolonged stays (> 7 days) occurred in 3.5% (LSG) vs. 3.6% (LRYGB; p = 0.863).
Conclusion
Both procedures demonstrated low complication and mortality rates in routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School and University Medical Center OWL, Mara Hospital, University Clinic for People with Neurodevelopmental Disorders, Bielefeld University, Maraweg 21, 33617, Bielefeld, Germany.
- Department of Abdominal, Tumor, Transplant and Vascular Surgery, Cologne-Merheim Medical Center, Witten/Herdecke University, Ostmerheimer Str. 200, 51109, Cologne, Germany.
- Department of General and Visceral Surgery, Thoracic Surgery and Proctology, Medical Campus OWL, University Hospital Herford, Ruhr University Bochum, Schwarzenmoorstr. 70, 32049, Herford, Germany. andreas.krieg@rub.de.
- Epidemiology, IQVIA, Frankfurt, 60549, Germany.
Förderung
- Ruhr-Universität Bochum
Zitieren
APA
Krieg, S., Eisenberger, C. F., Krieg, A., & Kostev, K. (2026). In-hospital outcomes following sleeve gastrectomy and Roux-en-Y gastric bypass: a real-world multicenter study in Germany. Langenbeck's Archives of Surgery, 411(1). https://doi.org/10.1007/s00423-026-04064-9
Vancouver
Krieg S, Eisenberger CF, Krieg A, Kostev K. In-hospital outcomes following sleeve gastrectomy and Roux-en-Y gastric bypass: a real-world multicenter study in Germany. Langenbeck's Archives of Surgery. 2026;411(1). doi:10.1007/s00423-026-04064-9
BibTeX
@article{Krieg2026,
author = {Krieg, Sarah and Eisenberger, Claus F and Krieg, Andreas and Kostev, Karel},
title = {In-hospital outcomes following sleeve gastrectomy and Roux-en-Y gastric bypass: a real-world multicenter study in Germany},
journal = {Langenbeck's Archives of Surgery},
year = {2026},
volume = {411},
number = {1},
doi = {10.1007/s00423-026-04064-9}
}
EUVIMED